Patent · US Active

C3-binding agents and methods of use thereof

US11767359B2 · kind B2 · utility

0Cited by

8References

19Claims

0Family size

Assignee

NGM Biopharmaceuticals, Inc. · US

Inventors

Dana Yen Mei Duey · Burlingame, US
Zhonghao Liu · Redwood City, US
Jie Tang · Singapore, SG
Yan Wang · San Diego, US
Yiyuan Yin · Fremont, US
Wenwu Zhai · Redwood City, US
Jared Martin Higbee · San Francisco, US

Key dates

Filing date	Aug 19, 2021
Grant date	Sep 26, 2023
Priority date	—
Expiry date	Aug 19, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides binding agents, such as antibodies (including single chain variable fragments), that specifically bind complement component C3, including human C3, compositions comprising same, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.